[Low doses of quetiapine (Seroquel) as an impulsivity corrector in patients with bipolar affective disorder in remission].
Margarita A MorozovaS S PotaninD S BurminskiyA G BeniashviliG E RupchevT A LepilkinaM Yu SorokinEvgeny D KasyanovGalina N MazoD A TarumovA G TrufanovK V MarkinT Z BeybalaevaA A KatokD S TsapkoPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2022)
The results of the study showed that add-on of the low doses of quetiapine (Seroquel) significantly decreases impaired impulse control in remitted patients with bipolar affective disorders both in self-evaluation and in risk-taking experimental test. The drop of high level of impulsivity can improve the quality and stability of remission and reduce behavioral risks due to impaired impulse control.